Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 8/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.52 |
| ▸ | STS | P08842 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25184218 | 0.90 | ELANE (0.50) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL28324296 | 0.89 | SRC (0.67) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL14672258 | 0.88 | ELANE (0.49) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL20508785 | 0.88 | ELANE (0.49) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL20508796 | 0.88 | ELANE (0.49) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL19261213 | 0.87 | SRD5A2 (0.51) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL14672257 | 0.87 | SRC (0.64) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL12198434 | 0.86 | ELANE (0.58) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL10045721 | 0.84 | ELANE (0.51) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL15326120 | 0.83 | ELANE (0.59) | ELANEALDH1A1SRD5A2STSGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098225-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | SURMODICS INC (US) | 2026-04-09 | — | — | US | claimed |
| US-12441951-B2 | Polyacrylic acid containing lubricious coatings for medical devices with enhanced properties | SURMODICS, INC. (US) | 2025-10-14 | — | — | US | claimed |
| EP-4615530-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | SurModics, Inc. (US) | 2025-09-17 | — | — | EP | claimed |
| EP-4489804-A1 | THROMBORESISTANT COATINGS, COATED DEVICES, AND METHODS | Surmodics Coatings, LLC (US) | 2025-01-15 | — | — | EP | claimed |
| US-20240240098-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | BANK OF MONTREAL, AS COLLATERAL AGENT | 2024-07-18 | — | — | US | claimed |
| WO-2024102465-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | SURMODICS, INC. (US) | 2024-05-16 | — | — | WO | claimed |
| WO-2023172686-A1 | THROMBORESISTANT COATINGS, COATED DEVICES, AND METHODS | Surmodics Coatings, LLC (US) | 2023-09-14 | — | — | WO | claimed |
| EP-3581213-B1 | COATED MEDICAL DEVICE | SURMODICS INC (US) | 2022-07-06 | — | — | EP | claimed |
| US-10253193-B2 | Photoactivatable crosslinker | SURMODICS, INC. (US) | 2019-04-09 | — | — | US | claimed |
| EP-2552927-B1 | DEGRADABLE PHOTO-CROSSLINKERS | SURMODICS INC (US) | 2019-03-13 | — | — | EP | claimed |
| US-20180273773-A1 | PHOTOACTIVATABLE CROSSLINKER | BANK OF MONTREAL, AS COLLATERAL AGENT | 2018-09-27 | — | — | US | claimed |
| EP-2804915-B1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | SURMODICS INC (US) | 2016-03-30 | — | — | EP | claimed |
| WO-2026090506-A1 | MEDICAL DEVICE COATINGS AND METHODS | SURMODICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260108662-A1 | LUBRICIOUS COATING FOR MEDICAL DEVICE | SURMODICS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260098225-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | SURMODICS INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-12472288-B2 | Lubricious coating for medical device | SURMODICS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| WO-2011123441-A1 | DEGRADABLE PHOTO-CROSSLINKER | SURMODICS, INC. (US) | 2011-10-06 | — | — | WO | disclosed |
| WO-2011123441-A1 | DEGRADABLE PHOTO-CROSSLINKER | SURMODICS, INC. (US) | 2011-10-06 | — | — | WO | disclosed |
| US-20110245367-A1 | DEGRADABLE PHOTO-CROSSLINKER | SURMODICS, INC. (US) | 2011-10-06 | — | — | US | disclosed |
| US-20110245367-A1 | DEGRADABLE PHOTO-CROSSLINKER | SURMODICS, INC. (US) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108662-A1 | LUBRICIOUS COATING FOR MEDICAL DEVICE | MUC1, ADH1A, PTK2 | ELANE 2306/4885ALDH1A1 45/4885SRD5A2 2043/4885 |
| US-10253193-B2 | Photoactivatable crosslinker | GLO1, LCP1, PLOD1 | ELANE 3717/4885ALDH1A1 1430/4885SRD5A2 2458/4885 |
| US-20180273773-A1 | PHOTOACTIVATABLE CROSSLINKER | GLO1, LCP1, PLOD1 | ELANE 3717/4885ALDH1A1 1430/4885SRD5A2 2458/4885 |
| US-20260098225-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | CUTA, EED, SELP | ELANE 1715/4885ALDH1A1 135/4885SRD5A2 1647/4885 |
| US-20110245367-A1 | DEGRADABLE PHOTO-CROSSLINKER | LCP1, GLO1, PLOD1 | ELANE 3629/4885ALDH1A1 1689/4885SRD5A2 2582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.